Tag: NANS 2025
Saluda announces new clinical data and multiple award-winning presentations at NANS...
Saluda Medical has announced the recent presentation of new clinical data at the 2025 North American Neuromodulation Society (NANS) annual meeting (30 January–1 February,...
SPR announces presentation of four abstracts featuring Sprint PNS system at...
SPR Therapeutics has announced the presentation of four featured abstracts at the 2025 North American Neuromodulation Society (NANS) annual meeting (30 January–1 February, Orlando, USA)....
Abbott showcases four-year REALITY study data on BurstDR SCS technology
Abbott has announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR spinal cord stimulation (SCS) technology provides for patients...
New data indicate significant pain relief and reduced opioid use with...
Biotronik Neuro will unveil new data from the BENEFIT-03 clinical study at the upcoming North American Neuromodulation Society (NANS) annual meeting (30 January–1 February...
Saluda receives US FDA approval for automated programming platform in spinal...
Saluda Medical has announced the US Food and Drug Administration (FDA) approval of its biomarker-based, automated patient programming platform in spinal cord stimulation (SCS), representing...
North American Neuromodulation Society announces 2025 award recipients ahead of annual...
The North American Neuromodulation Society (NANS) has announced its 2025 award winners ahead of the NANS annual meeting (30 January–1 February, Orlando, USA), recognising...
